FibroGen Inc
NASDAQ:FGEN

Watchlist Manager
FibroGen Inc Logo
FibroGen Inc
NASDAQ:FGEN
Watchlist
Price: 7.35 USD 18.74% Market Closed
Market Cap: 29.4m USD
Have any thoughts about
FibroGen Inc?
Write Note

Wall Street
Price Targets

FGEN Price Targets Summary
FibroGen Inc

Wall Street analysts forecast FGEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FGEN is 10.2 USD with a low forecast of 10.1 USD and a high forecast of 10.5 USD.

Lowest
Price Target
10.1 USD
37% Upside
Average
Price Target
10.2 USD
39% Upside
Highest
Price Target
10.5 USD
43% Upside
FibroGen Inc Competitors:
Price Targets
SPRY
ARS Pharmaceuticals Inc
79% Upside
DBV
DBV Technologies SA
108% Upside
IONS
Ionis Pharmaceuticals Inc
39% Upside
KRYS
Krystal Biotech Inc
41% Upside
UTHR
United Therapeutics Corp
32% Upside
096530
Seegene Inc
30% Upside
EXEL
Exelixis Inc
7% Downside
SYRE
Spyre Therapeutics Inc
247% Upside

Revenue
Forecast

Revenue Estimate
FibroGen Inc

For the last 11 years the compound annual growth rate for FibroGen Inc's revenue is -11%. The projected CAGR for the next 3 years is -30%.

-11%
Past Growth
-30%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Operating Income
Forecast

Operating Income Estimate
FibroGen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
18%
Average Beat

Net Income
Forecast

Net Income Estimate
FibroGen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-18%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is FGEN's stock price target?
Price Target
10.2 USD

According to Wall Street analysts, the average 1-year price target for FGEN is 10.2 USD with a low forecast of 10.1 USD and a high forecast of 10.5 USD.

What is FibroGen Inc's Revenue forecast?
Projected CAGR
-30%

For the last 11 years the compound annual growth rate for FibroGen Inc's revenue is -11%. The projected CAGR for the next 3 years is -30%.

Back to Top